| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000023231 |
| Receipt No. | R000024981 |
| Official scientific title of the study | sarcopenic state in preoperative patients |
| Date of disclosure of the study information | 2016/07/19 |
| Last modified on | 2016/07/19 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | sarcopenic state in preoperative patients | |
| Title of the study (Brief title) | sarcopenic state in preoperative patients | |
| Region |
|
|
| Condition | ||||
| Condition | Disease undergoing surgery and rehabilitation | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | to investigate sarcopenic state in perioperative patients |
| Basic objectives2 | Others |
| Basic objectives -Others | no |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | muscle mass
|
| Key secondary outcomes | muscle strength
Barthel Index |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | questionnaire | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients undergoing surgery in anesthesiology management | |||
| Key exclusion criteria | Patients who can't answer to BI.
Patients who undergo re-operation in hospitalization. Patients who can't well understand Japanese Patients who can't undergo evaluation of muscle mass and strength. Patients who can't undergo rehabilitation. |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Kawaguchi Masahiko |
| Organization | Nara Medical University |
| Division name | Anestesiology |
| Address | 840 Shijo-cho, Kashihara, Nara 634-8522, Japan |
| TEL | 0744-22-3051 |
| drjkawa@gmail.com | |
| Public contact | |
| Name of contact person | Kido akira |
| Organization | Nara Medical University |
| Division name | Orthopedics |
| Address | 840 Shijo-cho, Kashihara, Nara 634-8522, Japan |
| TEL | 0744-22-3051 |
| Homepage URL | |
| akirakid@naramed-u.ac.jp | |
| Sponsor | |
| Institute | Nara Medical University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Nara prefecture |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | intervention study
Everyone who meet the selection criteria in patients who underwent surgery at our facility in April 2016-March 2018 we finish to gather the patients when 600 patients were entried. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024981 |